Edwards’ Ecliptis Wins FDA Clearance, Challenges AtriCure in Surgical LAA Market
Edwards got FDA OK for heart clip; it enters a market led by AtriCure, adding competition but not changing the outlook much.
/ 3 items
#MDT↓
Edwards Lifesciences Gets Big Boost as CMS Expands TAVR Coverage to Asymptomatic Patients
TAVR is Edwards’ main business. New CMS rules could boost sales and help it take market share from Medtronic and Boston Scientific.
Medtronic to Acquire SPR Therapeutics for $650M to Expand Chronic Pain Treatment Options
Medtronic will buy SPR Therapeutics for a 60-day device that uses gentle nerve signals to reduce chronic pain without drugs.